Editorial Board
Venkatesh Ponemone
Executive Director, Clinical Development & Operations TotipotentRX Cell Therapy Pvt. Ltd. Manipal University Gurgaon, Haryana, India · India
Editorial leadership for International Journal of Blood Transfusion ISSN 3070-1937
Research interests
- Stem Cells Transplantation
- Tissue Repair
- Regeneration
- Cord Blood Haploidentical Transplantation
Biography
Awards/ Honors:
- Awarded as “Star performer of the year” (one among 3 employees with highest rating) for FY 2015-2016 among all the Global employees across both US and India for the Clinical development contribution, meeting corporate goals and objectives and to achieve key milestones during annual appraisal.
- Awarded as “Star performer of the year” (one among 2 employees with highest rating) for FY 2014-2015 among all the Global employees across both US and India for the Clinical contribution, meeting corporate objectives and key milestones during annual appraisal.
- Awarded “study Scholarship award”, International Biopharmaceutical Association (IBPA) Dec 2007 for Clinical Research Program at Kriger Clinical Research Institute, Canada.
- Awarded “Young Scientist Award” at “International conference on Recent Trends in Radiation Biology (2004), Bhabha Atomic Research Centre, Mumbai, India.
- Awarded “Best poster Award” at “International conference on Recent Trends in Radiation Biology (ICRTRB-2004)” and held at Bhabha Atomic Research Centre, Mumbai, India
- Awarded “Senior Research Fellowship” Indian Council of Medical Research (ICMR), Govt. of India, New Delhi.
- University topper in B.Sc. Final year chemistry at Osmania University. Hyderabad, India.
- College topper in B.Sc. at Shadan Degree College, Osmania University, Hyderabad, India.
Considering IJBT for your work?
This journal is guided by Venkatesh Ponemone (Executive Director, Clinical Development & Operations TotipotentRX Cell Therapy Pvt. Ltd. Manipal University Gurgaon, Haryana, India) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.